Sign In
Buy CLSD
$0.410
+0 (+0%)
At Close: Mar 13, 2026
Clearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive Officer
08:04pm, Wednesday, 11'th Mar 2020
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
Clearside Biomedical, Inc. to Host Earnings Call
06:30pm, Wednesday, 11'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 11, 2020 / Clearside Biomedical, Inc. (NASDAQ:CLSD) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 11, 2020
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
Clearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020
12:05pm, Wednesday, 26'th Feb 2020
ALPHARETTA, Ga., Feb. 26, 2020 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and.
Clearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society Meetings
12:05pm, Tuesday, 25'th Feb 2020
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
Clearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society Conferences
12:05pm, Wednesday, 05'th Feb 2020
ALPHARETTA, Ga., Feb. 05, 2020 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and.
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
12:51pm, Tuesday, 04'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Bioscie
Forensic Value Stock Analysis: The Highest Positive And Negative Scoring Stocks For February
03:20pm, Monday, 03'rd Feb 2020
The new February selections for both Positive and Negative Forensic Value stocks released in alternating months with the Piotroski-Graham Value selections. 11 P
SDRL, FCEL among premarket gainers
02:17pm, Tuesday, 28'th Jan 2020
Ocean Bio-Chem (NASDAQ:OBCI) +80% as its subsidiary Star brite announces registered EPA product kills the Coronavirus.Happiness Biotech Group (NASDAQ:HAPP) +70% on sales of Cordyceps Mycelia product
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch + Lomb, its leading global eye health business, and Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company ded
Will Clearside Biomedical Continue to Surge Higher?
11:28am, Monday, 20'th Jan 2020
As of late, it has definitely been a great time to be an investor in Clearside Biomedical.
A closer look at the new super-charged MacBook Pro - Capital Lifestyle
05:21am, Wednesday, 13'th Jun 2012
Apple chose its World Wide Developer Conference to release a raft of new and revamped products including iOS 6, cross-platform iMessage, A Kenyan lifestyle platform for digital storytelling.
